Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

891 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Progression of Gastrointestinal Injury During Antiplatelet Therapy After Percutaneous Coronary Intervention: A Secondary Analysis of the OPT-PEACE Randomized Clinical Trial.
He C, Li Y, Jiang X, Jiang MN, Zhao XX, Ma SR, Bao D, Qiu MH, Deng J, Wang JH, Qu P, Jiang CM, Jia SB, Yang SQ, Ru LS, Feng J, Gao W, Huang YH, Tao L, Han Y, Yang K, Wang XY, Zhang WJ, Wang BM, Li Y, Yang YL, Li JX, Sheng JQ, Ma YT, Cui M, Ma SC, Wang XZ, Li ZS, Liao Z, Han YL, Stone GW. He C, et al. Among authors: qu p. JAMA Netw Open. 2023 Nov 1;6(11):e2343219. doi: 10.1001/jamanetworkopen.2023.43219. JAMA Netw Open. 2023. PMID: 37976067 Free PMC article. Clinical Trial.
Association Between Platelet Glycoprotein IIb/IIIa Inhibition and In-Hospital Outcomes in ST-Elevation Myocardial Infarction Patients Treated with Coronary Thrombus Aspiration: Findings from the CCC-ACS Project.
Liu W, Li Z, Yang T, A G, Sun H, Liu H, Song X, Jin Z, Li L, Li Y, Hao Y, Liu J, Zhao D, Zhou X, Yang Q; CCC-ACS investigators. Liu W, et al. Cardiovasc Drugs Ther. 2024 Apr;38(2):315-325. doi: 10.1007/s10557-022-07398-w. Epub 2022 Nov 7. Cardiovasc Drugs Ther. 2024. PMID: 36342561
In-hospital outcomes of ticagrelor versus clopidogrel in patients 75 years or older with acute coronary syndrome: findings from the Improving Care for Cardiovascular Disease in China (CCC)-Acute Coronary Syndrome Project.
Yang N, Liu J, Liu J, Hao Y, Smith JSC, Huo Y, Fonarow GC, Ge J, Morgan L, Ma C, Han Y, Zhao D; Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) project investigators. Yang N, et al. Age Ageing. 2022 Nov 1;51(11):afac231. doi: 10.1093/ageing/afac231. Age Ageing. 2022. PMID: 36413586 Clinical Trial.
Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC-ACS (improving care for cardiovascular disease in China-acute coronary syndrome) project.
Wang Y, Geng Y, Zhang O, Xu Q, Xue Y, Zhou B, Zhang P; CCC-ACS Investigators. Wang Y, et al. Eur J Med Res. 2023 Feb 2;28(1):59. doi: 10.1186/s40001-023-01025-6. Eur J Med Res. 2023. PMID: 36732830 Free PMC article.
Improved specificity and efficacy of base-editing therapies with hybrid guide RNAs.
Whittaker MN, Brooks DL, Quigley A, Jindal I, Qu P, Wang JZ, Ahrens-Nicklas RC, Musunuru K, Alameh MG, Peranteau WH, Wang X. Whittaker MN, et al. Among authors: qu p. bioRxiv [Preprint]. 2024 Apr 23:2024.04.22.590531. doi: 10.1101/2024.04.22.590531. bioRxiv. 2024. PMID: 38712058 Free PMC article. Preprint.
Extended Clopidogrel Monotherapy vs DAPT in Patients With Acute Coronary Syndromes at High Ischemic and Bleeding Risk: The OPT-BIRISK Randomized Clinical Trial.
Li Y, Li J, Wang B, Jing Q, Zeng Y, Hou A, Wang Z, Liu A, Zhang J, Zhang Y, Zhang P, Jiang D, Liu B, Fan J, Zhang J, Li L, Su G, Yang M, Jiang W, Qu P, Zeng H, Li L, Qiu M, Ru L, Chen S, Zhou Y, Qiao S, Stone GW, Angiolillo DJ, Han Y; OPT-BIRISK Investigators. Li Y, et al. Among authors: qu p. JAMA Cardiol. 2024 Apr 17:e240534. doi: 10.1001/jamacardio.2024.0534. Online ahead of print. JAMA Cardiol. 2024. PMID: 38630489
891 results